While we provide in vitro evidence in support of a novel mechanism of regulation of E-cadherin in tamoxifen-resistant breast cancer, we understand that further animal studies are needed to validate these findings so that the information could be of use in future clinical trials. The gene discussed is CDH1; the disease is breast cancer.